Clarity Medical Group Holding Limited provided consolidated earnings guidance for the six months ended 30 September 2022. For the period, the company expects a decrease in profit attributable to owners of the Company in a range of approximately HKD 2.3 million to HKD 3.8 million for the Interim Period as compared to the same period in 2021, representing an expected drop of approximately 21% to 34%.